HeartSciences Inc. (HSCS) Financial Statements
Industry: Finance Services
In fiscal 2026, HeartSciences reported revenue of $4,319, down 0.7% from $4,350 the year before. Net income was -$9.1M (a -211666.5% net margin). Gross margin was 59.1% and operating margin was -194787.4%. Operating activities generated -$7.4M of cash, leaving -$7.4M of free cash flow.
Open the full interactive HeartSciences financials → Quarterly statements, key ratios, valuation history and price charts.
HeartSciences Key Stats
| Share Price | $3.09 |
|---|---|
| Market Cap | $11.3M |
| Revenue YoY Growth | -0.7% |
| 52-Week Range | $1.67 – $5.20 |
| Shares Outstanding | 3.7 million (basic, 2027 Q1) |
HeartSciences Income Statement
| FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|
| Revenue | $5,150 | $18,600 | $4,350 | $4,319 |
| Gross Profit | $2,354 | $12,519 | $2,470 | $2,551 |
| Operating Income | -$6.1M | -$6.3M | -$8.4M | -$8.4M |
| Pre-Tax Income | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| Income Tax | — | — | — | $0 |
| Net Income | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| Diluted EPS | -$80.00 | -$19.00 | -$9.34 | — |
HeartSciences Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $2,419 | $0 | $0 | $2,100 |
| Net Income | -$2.4M | -$2.0M | -$2.8M | -$3.2M |
| Diluted EPS | -$0.85 | — | — | — |
HeartSciences Balance Sheet
| FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|
| Cash & Equivalents | $1.7M | $5.8M | $1.1M | $1.7M |
| Current Assets | $2.7M | $7.4M | $2.2M | — |
| Total Assets | $3.3M | $9.5M | $4.2M | — |
| Current Liabilities | $1.8M | $1.8M | $3.7M | — |
| Total Long-Term Debt | $1.0M | — | — | — |
| Total Liabilities | $3.1M | $2.2M | $4.0M | — |
| Shareholders' Equity | $230,557 | $7.3M | $205,171 | $226,060 |
HeartSciences Cash Flow Statement
| FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|
| Cash From Operations | -$5.8M | -$6.1M | -$7.4M | -$7.4M |
| Cash From Investing | -$18,308 | -$125,271 | -$30,188 | -$44,452 |
| Cash From Financing | $6.5M | $10.3M | $2.7M | $8.0M |
| Free Cash Flow | -$5.8M | -$6.1M | -$7.4M | -$7.4M |
Figures from HeartSciences' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full HeartSciences financials page for every line item.
HeartSciences Company Profile
| Ticker | HSCS |
|---|---|
| Exchange | Nasdaq |
| Industry | Finance Services |
| Headquarters | Southlake, Texas |
| Incorporated in | Texas |
| Fiscal Year End | April 30 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001468492 |
Frequently Asked Questions
What was HeartSciences' revenue in fiscal 2026?
HeartSciences (HSCS) reported revenue of $4,319 for fiscal 2026.
What is HeartSciences' annual revenue history?
HeartSciences' annual revenue by fiscal year: 2023: $5,150; 2024: $18,600; 2025: $4,350; 2026: $4,319.
What was HeartSciences' net income in fiscal 2026?
HeartSciences reported net income of -$9.1M for fiscal 2026.
How much free cash flow did HeartSciences generate in fiscal 2026?
HeartSciences generated -$7.4M of free cash flow in fiscal 2026.
What was HeartSciences' revenue last quarter?
In its most recent reported quarter (2027 Q1), HeartSciences reported revenue of $2,100.
How many shares of HeartSciences are outstanding?
HeartSciences reported a weighted average of 3.7 million basic shares outstanding in 2027 Q1.
What is HeartSciences' market cap?
Based on its latest closing price, HeartSciences (HSCS) has a market capitalization of about $11.3M.
When does HeartSciences' fiscal year end?
HeartSciences' fiscal year end, as registered with the SEC, is April 30.
Where is HeartSciences headquartered?
HeartSciences lists its business address in Southlake, Texas in its SEC filings.